Covetrus (NASDAQ:CVET) celebrates the combination of two unique and complementary businesses – Henry Schein Animal Health and Vets First Choice – as a newly formed company. Covetrus will leverage decades-long experience, insights, technology and global [...]
Teckro has raised a fresh round of funding to accelerate its aim of helping to bring drugs and treatments to market quicker and more efficiently. The $25 million Series C round was led by Northpond [...]
Adimab, LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, today announced that 12 new partner programs entered clinical development in 2018. This brings the total number of [...]
Compass Therapeutics, a biotechnology company committed to the ambitious goal of comprehensively drugging the human immune system, today announced that it has been named by FierceBiotech as one of 2018’s Fierce 15 biotechnology companies, designating [...]
For over a decade and a half, the Built Environment Investment Team at Borealis Ventures has been funding and mentoring firms ready to build a better world. As the portfolio and market demand continued to grow, the decision to create a new dedicated venture strategy was a natural one. In 2018, we decided to leverage all of the expertise from the Borealis Ventures Built Environment Investment Team and give it even greater focus by forming Building Ventures, entirely committed to funding disruptive ideas in the built environment for a better built world.
We’re always interested in engaging with inventors, creators, and entrepreneurs to help develop ideas and realize visions.